User Guide for iCell Cardiomyocytes Assay on an xCELLigence RTCA CardioECR System
Technical Reference Summary
Covered Models & Document Scope
Optimized protocol for direct plating of one unit of iCell cardiomyocytes on an xCELLigence RTCA CardioECR system using E-Plate CardioECR 48 (Agilent p/n 300600940) and RTCA CardioECR system (Agilent p/n 380601210); covers Day 1 setup through Day 17 compound addition.
Section-by-Section Technical Breakdown
Lists the required xCELLigence RTCA CardioECR system, CO2 incubator, laminar flow hood, multichannel pipettors, E-Plate CardioECR 48, iCell cardiomyocytes kit, fibronectin stock, and DPBS. Part numbers are given for the instrument and consumable.
- RTCA CardioECR system: Agilent p/n 380601210
- E-Plate CardioECR 48: Agilent p/n 300600940
- Fibronectin stock: Sigma-Aldrich Cat. no. F1141
- 8-channel multichannel pipettor, 20 and 200 µL
Describes coating the E-Plate with fibronectin, measuring background, thawing/counting/seeding iCell cardiomyocytes, and replacing plating medium with maintenance medium. Includes critical cautions on room-temperature incubation, temperature equilibration, and warm medium.
- Dilute FN stock 1:100 in DPBS to 10 µg/mL; add 50 µL per well
- Incubate coated plate at 37 °C ≥1 h or 4 °C overnight
- Seed 20,000 cells/well; leave 30 min at RT in laminar flow hood
- Equilibrate 15 min in incubator before inserting into station
- Replace Plating Medium with Maintenance Medium 48 h after seeding
- Medium change every 48 h during culture
Covers routine maintenance medium changes every 48 hours and daily monitoring of beating activity and field potential until a synchronous beating profile is achieved. The coefficient of variation of beating period should be less than 10%.
- Replace maintenance medium every 48 hours
- Monitor beating activity and field potential daily
- CV of beating period during each recording should be <10%
Defines the QC measurement schedule and acceptance criteria for cardio mode (beating activity) and ECR mode (electrical activity). Includes recommended readings for BR, Amp, BRI, FR, and sodium spike amplitude.
- Five sweeps of 20-second durations, one-hour interval
- Cardio QC: BR >20 beats/min, Amp ≥0.07, BRI <0.1, CV <15%
- ECR QC: FR >20 times/min, 90% of electrodes detect >0.3 mV sodium spike, CV <15%
- Stable cardio signal normally achieved before stable FP signal
Details cell culture preparation, baseline measurement, compound preparation/dilution, and compound addition with short-term (<1 hour) or long-term (24 hours) monitoring schedules. Emphasizes minimizing compound addition time to 3–5 minutes.
- Replace culture media with 90 µL fresh 37 °C media at least 4 h before compound addition
- Baseline: seven sweeps of 60-second durations, five-minute interval
- Prepare 1000x concentrated serial dilutions; final 10x in culture medium
- Add 10 µL compound to E-Plate; include solvent-only negative control
- Short-term monitoring: 13 sweeps of 60-second durations, five-minute intervals
- Long-term monitoring: 24 sweeps of 60-second durations, one-hour intervals
- Compound addition should not exceed 3–5 minutes
Key Integration, Operating & Safety Requirements
| Specification / Condition | Engineering Implication | Applies To |
|---|---|---|
| Fibronectin coating concentration is 10 µg/mL prepared by 1:100 dilution of stock in sterile DPBS. p.2 ↗ | Ensures consistent extracellular matrix coating for cardiomyocyte attachment. | E-Plate CardioECR 48 |
| Coated E-Plate can be incubated at 37 °C for at least 1 hour or at 4 °C overnight. p.2 ↗ | Provides flexibility in experiment scheduling while maintaining coating integrity. | E-Plate CardioECR 48 |
| Seed 20,000 iCell cardiomyocytes per well in the E-Plate CardioECR 48. p.2 ↗ | Standardized cell density for reproducible beating and field potential signals. | iCell cardiomyocytes assay |
| After seeding, leave the plate in the laminar flow hood for 30 minutes at room temperature. p.2 ↗ | Critical for even cell distribution and reliable cell performance during the assay. | E-Plate CardioECR 48 |
| Allow 15 minutes for temperature equilibration before inserting the plate into the RTCA CardioECR station. p.2 ↗ | Prevents condensation on the plate bottom that would interfere with field potential signal assessment. | E-Plate CardioECR 48 |
| Impedance sampling rate is 2 or 12.8 ms; ECR sampling rate is 0.1 ms (10 kHz). p.3 ↗ | Defines temporal resolution for impedance and extracellular recording measurements. | RTCA CardioECR system |
| Replace plating medium with maintenance medium 48 hours after seeding and every 48 hours thereafter. p.3 ↗ | Maintains culture health and consistent assay conditions. | iCell cardiomyocytes culture |
| Beating signal should be detectable within 96 to 144 hours after cell seeding; beating frequency becomes more regular 10 days post-seeding. p.3 ↗ | Sets expectation for when to begin monitoring and when to schedule compound testing. | iCell cardiomyocytes assay |
| During daily monitoring, the coefficient of variation of beating period should be less than 10%. p.3 ↗ | Indicates a synchronous beating profile suitable for compound testing. | iCell cardiomyocytes assay |
| Cardio QC acceptance: BR >20 beats/min, Amp ≥0.07, BRI <0.1, CV <15% across recording time points. p.4 ↗ | Defines minimum cell status quality before compound addition. | iCell cardiomyocytes assay |
| ECR QC acceptance: FR >20 times/min, 90% of electrodes detect >0.3 mV sodium spike with consistent amplitude, CV <15%. p.4 ↗ | Ensures electrical activity is sufficiently robust for field potential measurements. | iCell cardiomyocytes assay |
| At least 4 hours before compound addition, replace culture media with 90 µL of fresh media equilibrated to 37 °C. p.5 ↗ | Ensures uniform medium volumes across the E-Plate due to variable evaporation rates. | E-Plate CardioECR 48 |
| Baseline measurement uses seven sweeps of 60-second durations with five-minute intervals. p.5 ↗ | Provides stable pre-treatment reference for beating and electrical activity. | RTCA CardioECR system |
| Prepare compound stock solutions at high concentration (ideally 1000-fold of highest test concentration) and store at -20 °C if DMSO is used. p.5 ↗ | Minimizes solvent toxicity and ensures accurate serial dilutions. | Compound preparation |
| Add 10 µL of compound diluted in culture medium from a V-bottom microplate to the E-Plate CardioECR 48. p.6 ↗ | Standardized compound transfer volume for reproducible dosing. | E-Plate CardioECR 48 |
| Compound addition should not exceed 3 to 5 minutes. p.6 ↗ | Minimizes exposure of cells to ambient temperature and oxygen outside the incubator, preserving signal capture. | Compound addition |
| Short-term monitoring schedule: 13 sweeps of 60-second durations with five-minute intervals; long-term: 24 sweeps of 60-second durations with one-hour intervals. p.5 ↗ | Defines data acquisition cadence for acute and chronic compound effects. | RTCA CardioECR system |
| Include wells treated with solvent only at the same final concentration as compound-treated wells for the negative control. p.6 ↗ | Controls for solvent effects in the assay. | Compound addition |
Technical Data
| Parameter | Value | Condition |
|---|---|---|
| Fibronectin coating concentration | 10 µg/mL p.2 ↗ | 1:100 dilution of FN stock in sterile DPBS |
| Fibronectin coating volume per well | 50 µL p.2 ↗ | E-Plate CardioECR 48 |
| Coating incubation temperature | 37 °C p.2 ↗ | at least 1 hour; alternatively 4 °C overnight |
| Background measurement duration | 1 second p.2 ↗ | preset Step 1 |
| Cell seeding density | 20,000 cells/well p.2 ↗ | iCell cardiomyocytes on E-Plate CardioECR 48 |
| Room-temperature incubation after seeding | 30 minutes p.2 ↗ | laminar flow hood, room temperature |
| Temperature equilibration before station insertion | 15 minutes p.2 ↗ | incubator |
| Impedance sampling rate | 2 or 12.8 ms p.3 ↗ | all schedule steps |
| ECR sampling rate | 0.1 ms (10 kHz) p.3 ↗ | all schedule steps |
| Medium change interval | 48 hours p.3 ↗ | during culture |
| Maintenance medium volume per well | 100 µL p.3 ↗ | medium change |
| Beating signal detection window | 96 to 144 hours p.3 ↗ | after cell seeding |
| Beating period CV during monitoring | <10 % p.3 ↗ | each recording |
| Beating Rate (BR) | >20 beats/min p.4 ↗ | Cardio mode QC |
| Beating Amplitude (Amp) | ≥0.07 p.4 ↗ | Cardio mode QC |
| Beating Rhythm Irregularity (BRI) | <0.1 p.4 ↗ | Cardio mode QC |
| CV across recording time points (Cardio QC) | <15 % p.4 ↗ | BR and Amp |
| Firing Rate (FR) | >20 times/min p.4 ↗ | ECR mode QC |
| Sodium Spike Amplitude detection | >0.3 mV p.4 ↗ | 90% of electrodes |
| CV across recording time points (ECR QC) | <15 % p.4 ↗ | FR and sodium spike amplitude |
| Fresh medium volume before compound addition | 90 µL p.5 ↗ | at least 4 hours before compound addition, 37 °C |
| Compound stock storage temperature | -20 °C p.5 ↗ | DMSO stock, ideally 1000-fold of highest test concentration |
| Compound addition volume | 10 µL p.6 ↗ | from V-bottom microplate to E-Plate CardioECR 48 |
| Maximum compound addition duration | 3 to 5 minutes p.6 ↗ | to capture electrical and beating activity changes |